New study aims to protect kids from TB with shorter daily treatment
NCT ID NCT07124559
First seen Feb 03, 2026 · Last updated May 17, 2026 · Updated 12 times
Summary
This study is testing a 28-day daily treatment (rifapentine plus isoniazid) to prevent tuberculosis (TB) in children under 13 years old, including those with HIV. About 144 children will take part, split into two groups based on HIV status. The goal is to find the best dose and ensure the treatment is safe and tolerable for all children.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUBERCULOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Baylor-Uganda (Site ID: 31798)
Kampala, Uganda
-
Chiangrai Prachanukroh Hospital (Site ID: 5116)
Chiang Rai, 57000, Thailand
-
Gaborone (Site ID: 12701)
Gaborone, Botswana
-
Harare Family Care (Site ID: 31890)
Belgravia, Harare, Zimbabwe
-
Kenya Medical Research Institute, Walter Reed Project Clinical Research Center (Site ID: 5121)
Kericho, 20200, Kenya
-
Les Centres GHESKIO (Site ID: 30022)
Port-au-Prince, HT-6110, Haiti
-
MU-JHU Care Limited (Site ID: 5126)
Kampala, Uganda
-
Molepolole (Site ID: 12702)
Gaborone, Botswana
-
Seke North (Site ID: 30306)
Belgravia, Harare, Zimbabwe
-
Siriraj Hospital, Mahidol University (Site ID: 5115)
Bangkok, Bangkoknoi, 10700, Thailand
-
St Mary's (Site ID: 30303)
Chitungwiza, Zimbabwe
Conditions
Explore the condition pages connected to this study.